Protease inhibitors trace their roots back to laboratory work in the middle of the twentieth century. Researchers studying protein degradation noticed that uncontrolled proteolysis often interfered with experiments, so they went looking for ways to halt those reactions. Early protease inhibitor cocktails grew out of simple biological experiments using natural compounds found in plant extracts, egg whites, and blood plasma, which could block unwanted enzymatic activity. As molecular biology advanced, companies began to mix selective chemical inhibitors targeting serine, cysteine, aspartic, and metalloproteases for a broader protective effect in protein samples. Their work not only improved research accuracy but made large-scale protein purification and pharmaceutical development feasible, opening doors in everything from cancer studies to vaccine science. This innovation demonstrates how a targeted approach — informed by patient laboratory frustration — can fuel a cascade of advances that power modern science.
A typical protease inhibitor cocktail aims to stop proteases from digesting valuable proteins. Scientists usually reach for a tube of this cocktail when they need to keep protein extracts or cell lysates stable for downstream analysis. Commonly, manufacturers bundle inhibitors against serine, cysteine, and metalloproteases together, sometimes throwing in extra molecules to defend against less common enzymatic threats. Lab workers tend to trust a handful of global suppliers who conduct purity checks and keep tabs on the composition — since slight changes can mean lost samples or ruined data. Over time, companies fine-tuned these blends to support a range of buffer systems and temperature settings, recognizing that no two labs handle exactly the same experimental designs. As new applications in structural biology, proteomics, and medical diagnostics emerged, the range of cocktail types multiplied, sometimes reflecting regional research traditions or patented improvements.
Most protease inhibitor cocktails arrive in a lyophilized powder or concentrated liquid. These products often dissolve with ease in water or physiological buffers. They don't lower the pH dramatically, and their components resist oxidation, since many active principles like phenylmethylsulfonyl fluoride (PMSF) or aprotinin remain stable under refrigeration or even brief ambient exposure. Some might emit a mild chemical odor, but for most, the ingredients remain scent-free and nearly colorless. Storage remains critical: leave certain inhibitors out too long, or expose them repeatedly to freeze-thaw cycles, and the potencies can drop off or combine into unwanted byproducts. Formulators learned to select chemical forms — salts, pre-dissolved stocks — to allow longer shelf life, especially in busy communal labs.
Bottles carry dense but vital information. Labels define the inhibitor types and their concentrations, storage temperature, reconstitution guidance, and hazard codes based on regional regulations. Specificity matters: Some cocktails work best avoiding chymotrypsin, others skew towards metalloproteases. Researchers may scan for batch number, recommended dilution factor (usually a 100X or 1000X concentrate), and expiration date, which guarantees that their protein experiments stay protected over the product's advertised window. Better brands also include technical data sheets with suggested application amounts for tissue, blood, or cell culture. If the product supports mass spectrometry or clinical workflows, labeling rules get even tighter, thanks to national agencies watching product traceability and chemical content. This transparency carries weight: trust builds on the ability to check each batch for reproducibility, so big laboratories tend to log every lot for statistical analysis and troubleshooting.
In the factory, mixing a protease inhibitor cocktail doesn’t just mean dumping ingredients together. Operators weigh and blend select high-purity chemical inhibitors under nitrogen to avoid moisture and oxidation. Blending proceeds in batches that minimize cross-contamination, and each lot gets tested for activity using protein substrates spiked with sample proteases. Once confirmed, the blend gets poured off into vials for drying or aliquoting. In the lab, users almost always dissolve cocktails in cold, freshly prepared buffer, never heating the solution to avoid denaturing the inhibitors. Small aliquots prevent waste — if the cocktail sits too long in solution, the more volatile components like AEBSF or PMSF start breaking down. Before adding to samples, many protocols call for a short spin to collect any condensation and a gentle inversion to guarantee complete re-suspension. Anyone dealing with especially dirty or unknown samples will sometimes double the concentration, hoping to outpace endogenous protease bursts during cell lysis.
Adding a cocktail stops proteases cold through a mix of chemical and molecular tricks. Some inhibitors, like leupeptin and E-64, form covalent bonds with protease active sites, permanently disabling those enzymes. Others block enzyme-substrate docking pockets using reversible binding — as seen with EDTA or EGTA for metalloproteases, which yank away essential metal ions. Chemistry teams sometimes tweak the compounds, swapping functional groups to increase stability or cut down cross-reactivity. Newer cocktails might feature encapsulation technology, microbeads, or slow-release matrices, giving labs more time before degradation kicks in. Success in this area grew from observing specific enzyme-inhibitor kinetic interactions in real-world use, moving past theoretical models. In some cases, small tweaks to inhibitor ratios drove big improvements for downstream compatibility, like with label-free proteomics or antibody pulldown. Trial and error — closely paired with analytical chemistry — refined these blends from blunt tools into surgical solutions for the modern biochemist.
Companies market protease inhibitor cocktails under a dizzying array of names. You might encounter terms like "Complete Protease Inhibitor Tablets," "Universal Protease Blocker," or "Multiplex Inhibitor Mix," each reflecting some unique formula or targeted enzyme class. Regional names vary as well, with "Anti-proteolytic Complex" being common across certain medical suppliers. Chemical catalogs keep a cross-index of synonyms for standard compounds inside, like PMSF also listed as "Phenylmethanesulfonyl Fluoride." Patent disputes and regulatory rules shape product branding — slight tweaks to formula or delivery method trigger new names recognized by procurement officers and researchers alike. This nomenclature mess sometimes frustrates scientists comparison-shopping, but consults with product support teams or literature can clarify which blend mirrors established protocols, cutting down on lost sample risk.
Working with protease inhibitor cocktails demands attention to chemical safety. Many popular inhibitors, PMSF in particular, are toxic and volatile, needing handling in fume hoods and strict glove use. Labels spell out eye and skin irritant warnings, and safety data sheets explain risks of inhalation. Disposing of unused solution or expired stocks involves chemical waste bins, not sink drains, due to persistent environmental toxicity. In regulated labs, supervisors oversee chemical storage and require annual training, so even all-night graduate students remember to wear PPE and avoid accidents. Teams keep spill kits and eyewash stations close, since one bad slip can cause lasting injury. Producers must follow international manufacturing standards like GMP or ISO, guaranteeing batch consistency, chemical traceability, and rigorous documentation for health agencies. All these efforts build a culture where convenience of protein preservation never trumps safety, even under deadline.
Protease inhibitor cocktails find homes in every major research discipline using proteins. Molecular biologists reach for them during tissue homogenization, hoping to preserve fragile kinases or transcription factors that break down in minutes post-harvest. Drug discovery labs use cocktails in target validation, keeping membrane proteins intact long enough for binding assays or crystallography. In diagnostics, companies stabilize serum samples for hours, securing patient test accuracy against uncontrolled protein loss. Environmental scientists and food technologists found value in protecting enzymes during extraction from plants or animal tissues, allowing precise analysis of food allergens or toxins. Some manufacturers even tailor their mix for high-throughput screening robots, banking on batch-to-batch consistency that machinery demands. Across each application, the basic need stays constant: block unwanted protein breakdown and guard investment in time, sample, and reagents spent preparing precious material.
Modern R&D surrounding protease inhibitor cocktails stretches far beyond simple stabilizer blends. Biochemists keep searching for new classes of inhibitors uncovered through next-generation screening — looking in exotic plant extracts, extremophile microorganisms, and engineered peptides. Advances in computational modeling support the design of selective inhibitors for previously overlooked protease classes, narrowing the window for unwanted cross-reactivity. Collaborations between academic labs and biotech firms push boundaries, adding inhibitor components suited for rare or hyper-reactive proteases found in emerging pathogens or unusual cell types. Researchers run high-throughput assays, leveraging fluorescent and mass spectrometry readouts to optimize concentrations for novel sample types. Companies invest in improving product shelf life, looking at smart packaging, lyophilization improvements, and microfluidic technologies for on-the-fly mixing, particularly useful in remote clinics or mobile diagnostics. Every advance in inhibitor chemistry reflects practical frustration from the bench and patient concerns in the clinic, driving cycles of feedback and ongoing refinement.
Few researchers overlook toxicity when choosing a protease inhibitor cocktail, since many classical agents have side effects that extend outside the flask. PMSF, for example, can trigger neurotoxicity or respiratory issues in exposed workers. Early toxicity screens dove into animal models, revealing chronic hazards at low concentrations, especially if disposal procedures or lab hygiene slipped. Modern regulatory agencies request full toxicological breakdowns, covering everything from acute oral and dermal exposure to possible carcinogenicity or mutagenic risk. Companies test not just the complete cocktail but breakdown products after long-term storage or environmental release. These studies occasionally prompt reformulations, replacing historic ingredients with newer, less dangerous analogs. The burden of proof now rests squarely on manufacturers, requiring self-funded research programs to maintain market access and protect laboratory workers world-wide.
Looking to the future, protease inhibitor cocktails will keep evolving as research needs grow more complex. Improvements in chemical synthesis and screening may uncover inhibitors tuned to specific protease isoforms, opening greater selectivity for clinical and pharmaceutical development. Digital integration — on-cartridge mixing or AI-driven adjustment based on sample feedback — may soon deliver made-to-order cocktails within minutes, tailored to each research project or patient need. As protein-based medicines develop, the pharmaceutical sector will pressure suppliers to meet new cGMP guidelines, guaranteeing absence of off-target interference. Greener chemistry, reducing environmental impact and human toxicity, will push companies to ditch hazardous classics in favor of biodegradable, targeted inhibitors. The role of regulatory harmonization will only grow: oversight will demand clearer product labeling and better data on downstream compatibility, especially as cocktail use explodes in diagnostics, personalized medicine, and cell therapies. Scientists and manufacturers must stay nimble, responding to evolving biology and safety demands — a challenge baked into the product’s history and likely to shape its destiny.
I remember the first time someone handed me a small vial labeled “protease inhibitor cocktail.” At first glance, I didn’t think much of it. Just another chemical on a cluttered shelf. Later, I realized that these little mixtures protect research work from going down the drain—sometimes literally.
Living cells don’t just hold together for the fun of it. Inside every cell, enzymes like proteases act as tiny tools or sometimes as demolition crews. Once you pull cells apart to study their inner workings, you unleash these proteases, which can rip up valuable proteins before you even get a good look at them. That’s where the cocktail steps in.
A protease inhibitor cocktail is a blend of compounds that shuts down these enzymes right away. Scientists reached for cocktails instead of single inhibitors because one enzyme rarely acts alone. A cocktail covers a wider range of proteases, much like a well-staffed football team covers more ground. Without this defense, proteins intended for study would break down and disappear from your sample. Research would turn up empty-handed results, wasting time and resources.
Proteins run most of life's machinery: from carrying messages to driving metabolic reactions. Studying diseases like Alzheimer’s or cancer often boils down to finding out what proteins do, how they change, or where they become damaged. If the sample’s proteins break down before you can test them, the whole story is lost. For example, missing pieces of proteins can skew the analysis, leading to errors in diagnostics or misunderstandings of how a disease progresses. Reliable data starts with intact samples.
I’ve seen that many labs keep various cocktails on hand because different sources use different proteases. Research on human tissue may face a different complement of enzymes compared to bacterial samples. Many off-the-shelf cocktails combine inhibitors for serine, cysteine, aspartic, and metalloproteases. By picking the right cocktail, researchers defend against the full network of molecular scissors lying in wait.
But not every protease inhibitor suits every experiment. Some cocktails react with substances in the sample or mess with certain tests by tossing an ingredient into the mix that interferes with measurement. This isn’t trivial—choosing poorly can lead to false clues or wasted money. Also, these inhibitors don’t last forever. A cocktail left sitting at room temperature or with too much freeze-thaw breaks down, failing to protect the sample. Regular training and careful record-keeping help keep experiments on track and prevent those easy mistakes.
There’s room for choices beyond the standard pre-mixed options. Some scientists mix their own combination for specific challenges, sometimes guided by tech support from the manufacturers or recent literature. High-quality options usually list the exact make-up, so you know exactly what goes into your experiment. Sharing tips across labs also helps, as one group’s solution may solve another’s stubborn issue.
A protease inhibitor cocktail may look simple, but it carries a big responsibility. It stands between years of research work and a cascade of ruined samples. In my experience, those tiny vials with their cryptic labels don’t just save proteins; they often save projects.
Protease inhibitor cocktails play a huge role in keeping protein samples intact in research labs. These delicate mixes block enzymes that break down proteins, which can wreck experiments. Tossing a tube in a random lab drawer doesn’t protect activity or reliability. Speaking from personal experience in biochemistry labs, mishandling these cocktails can drain a budget fast. Just one poorly prepared batch can ruin days of work and months of funding.
Most commercially available protease inhibitor cocktails come either as powders or liquid solutions. Powders seem like they might last forever, but they break down if exposed to heat or moisture. Liquid mixes go bad even faster without proper storage. Based on classic lab wisdom, the refrigerator is your cocktail’s best friend. Keeping the cocktail at 2–8°C shields it from enzyme activity and bacterial growth. Some researchers freeze small aliquots at –20°C to stretch shelf life even further.
I once made the mistake of keeping a bottle at room temperature on a bench. By next week, strange results cropped up—western blot bands went missing, and proteolysis wrecked key samples. That taught me to treat these cocktails as I would milk or fresh cheese: keep them chilled and away from light.
Using large bottles or tubes is tempting, but repeated freeze-thaw cycles sap a cocktail’s stopping power. Breaking down the stock into smaller aliquots solves this. Each aliquot gets used up quickly, and the rest stay untouched in the cold. No thawing and freezing over and over. This change can feel like a chore, yet it stops wasted money and hours down the drain. Don’t let the urge to “just grab and go” cost you more in repeated experiments.
A clear, simple label makes life easier if multiple people share the fridge. I’ve seen folks reach for someone else’s stock by accident because the labels didn’t match. Date everything, jot down concentrations, and add a name. Avoid confusion, and it becomes easier to spot cocktails drifting toward expiration. Many labs keep a log near the fridge, so everyone stays updated on what’s fresh.
Good storage isn’t an abstract ideal. It’s science in action, lowering the risk of sample loss and bitter surprises in experiment results. Peer-reviewed studies show most inhibitors break down if left warm for even a couple of days. Manufacturers recommend cooling for a reason. Trust the advice—especially with expensive samples or precious cell lysates on the line.
Many labs aim for reproducibility, and ruined reagents wreck that trust. Clear protocols, careful aliquoting, and an organized cold space set up everyone for success. Regularly review expiration dates and try to use an aliquot soon after thawing. Toss mixtures that look cloudy or have precipitates, as those signs often mean breakdown has started.
Every scientist wants reliable, clean data. Mishandling a protease inhibitor cocktail cuts corners and piles up headaches. Colleagues share your fridge and your goals—give the reagents the treatment you wish everyone else did. If the goal is consistent results and less waste, respect for proper storage truly makes the difference, both in the data and in the day-to-day life of a lab.
Choosing the proper concentration for any solution, from disinfectants in hospitals to fertilizers in the backyard, has always carried practical weight. Anyone who’s ever tried to clean a stubborn stain or boost tomato plant growth already knows that more isn’t always better, although the seductive logic of “stronger means it works better” still lingers everywhere. Real use cases teach hard lessons—damage to delicate surfaces, burnt leaves on prized plants, or worse, dangerous health consequences for kids and pets who wander where they shouldn't.
People tend to trust labels, but many “ready-to-use” products shy away from sharing the science behind those numbers. The CDC, EPA, and even gardeners' associations often publish guidelines for specific items—say, chlorine bleach at 0.1% for surface disinfection—because research backs up those figures. Too weak, and pathogens stick around. Too strong, and you risk corrosion, increased toxicity, or money literally going down the drain.
The story repeats elsewhere. Gardeners get burned (and so do their seedlings) when nitrogen-heavy fertilizers are dumped out “just to be sure.” Lists like those from the University of California’s agriculture program advise sticking with 1 tablespoon per gallon for most household plant foods. Pool owners check charts constantly, shaving costs and avoiding cloudy, unsafe water. Real numbers come from real testing—skipping these creates uncertain, even hazardous, results.
Overdosing costs more than supplies. Friends who’ve worked as janitors or in commercial kitchens will tell you about cracked hands, headaches, and breakouts from scrubbing too long with cleaning solutions mixed “a little stronger.” Some even witnessed children or pets getting sick because a floor never truly rinsed clean. It’s not scaremongering; these stories dot online forums and hospital logs alike.
Medical journals point to outbreaks traced not to new bugs, but to diluted cleaning routines or careless measurements. Every recommended concentration—often backed up by decades of data—serves as a balance point between safety, effectiveness, and cost. Skipping these numbers is a gamble. No seasoned facility manager, urban farmer, or parent with a medicine dropper would risk guessing.
Real improvement comes from easy-to-follow labels, measuring tools right in the container caps, and education. Imagine instructions broken down for someone rushing after a spill, or someone for whom English is a second language. A simple pictogram or color-coded guide beats a wall of fine print every time.
Manufacturers should keep pushing for transparency. Clear directions, accurate measuring kits in every box, and reminders about local regulations matter more than “kills 99%” stickers ever could. On the user side, a quick read through reputable websites—CDC, EPA, cooperative extensions—before using anything new pays off, just like glancing at a recipe before cooking for a crowd.
Finding answers to “what concentration should I use?” boils down to respecting proven numbers, learning from past mistakes, and choosing simplicity over guesswork. It protects hands, plants, kids, and wallets—sometimes all at the same time.
Spend enough time in a lab, and you'll see the word “cocktail” thrown around to describe reagent mixes prepared for a range of testing jobs. It sounds simple: one well-formulated bottle, ready for action, no matter what lands in your test tubes. People hope a single solution can cut through any matrix—think blood, urine, soil, water, tissue. Truth is, those hopes usually run right into the walls built by real science and real messes.
I’ve handled plenty of sample types, from tricky plant tissues to greasy environmental samples. Each type fights back in its own way. Nothing behaves like pure water in the real world. Salts, proteins, fats, and unknown chemicals turn basic tests sideways. A so-called universal cocktail stumbles when enzymes lose their punch in a fatty matrix or surfactants get swamped by soil particles.
Take blood. Protease inhibitors break down fast under some conditions. Urine can bring its own enzyme blockers. Soil often grabs and holds on to key reactants, demanding more power or different chemistry. The same cocktail mix won’t pull double duty, no matter what advertising says.
Big pharma and diagnostic companies keep hunting for that “one fits all” magic. They want quicker validations, fewer stockrooms full of glass bottles and less retraining. The business reason makes sense. On paper, launching a cocktail that “sorts everything” saves time and cash. Some solutions come close for closely-related clinical samples—but lab workers learn fast that outliers show up more than expected.
Published studies back it up. A 2021 evaluation from the Journal of Applied Biosciences tracked recovery rates of target molecules from common cocktails across blood, plasma, and urine. Consistency dropped across the board once the recipe got stretched beyond its original sample. The team found three different protein cocktails that only met reliability cutoffs for two out of the five sample panels. Losing even one sample type dropped confidence for diagnostics and forensics alike.
Innovation still counts for something. Bioengineers and chemists push new mixes—stabilized enzymes, wider-molecule detergents, and “smart reagents” to catch a broader swath. These products improve some bottlenecks and keep hope alive for a more flexible future. But every batch in my experience still calls for adaptation. Running controls and reading the fine print on every bottle stays critical, even as cocktails get smarter.
Best practice means vetting the mix before betting a week’s work on it. Labs don't settle for old habits; they compare recovery rates, check for interference, and adapt protocols time after time. It makes sense that there’s no single hero solution. Real samples just keep finding ways to challenge the chemistry. It’s part of the job, part of why lab work keeps your brain engaged. Instead of chasing a universal cocktail, the smartest approach sticks with questions, keeps checking results, and stays ready to tweak the mix—just like the world out there never quite matches the recipe.
Working in a research lab brings a certain rhythm. You grab a handful of chemicals, add a splash here, dash there, and hope that the results sing instead of fizzle. Blending inhibitors or reagents isn’t much different from tweaking your grandma’s stew recipe—except the flavors here translate to molecular outcomes. The question about whether this "cocktail" of inhibitors works well with other additives echoes across workbenches everywhere.
Compatibility in a chemical context doesn’t just stay at “will it explode?” Instead, it’s a lot about performance and reliability. Add a new ingredient (an inhibitor, a surfactant, or maybe a reducing agent) and you might upend the whole balance. Some colleagues admit they’ve spent weeks troubleshooting not a single substance, but the strange dance between two or three components.
Here’s the thing: enzymes can get touchy—so can most proteins or cells in solution. Some inhibitors do their job alone but struggle when paired with another. You’ll find dithiothreitol and EDTA in the same buffer fairly often, but toss in a complex metal chelator and something suddenly doesn’t add up. I once watched a simple trial balloon into hours of head-scratching because the classic protease inhibitor just flat-out refused to work with a phosphate buffer.
Over years in research, I’ve seen vendors tout “universal compatibility.” Lab folklore says, “Test it yourself. Trust comes after sweat.” Peer-reviewed studies help, yes, but nothing replaces a few side-by-side samples and careful observation. Many scientists like myself scour the literature and talk with colleagues before trying a new mix.
Fact is, harsh detergents play rough with enzyme inhibitors. Sodium azide wrecks some antibody cocktails. There’s always a chemical or two lurking in the mix that might cancel the benefits of an otherwise perfect blend. Peer experience—and sometimes even old lab notebooks—turn into the best guides for predicting standoffs or synergies.
Muddling through failed experiments burns both time and money. In biotech or clinical labs, the stakes run higher. An incompatible inhibitor cocktail can mean missed diagnoses or unreliable data. For example, an ill-designed inhibitor blend in cell lysate work can trigger unwanted enzyme activity, breaking down proteins before analysis even starts.
To add to this, reproducibility across labs has been under real scrutiny in recent years. Reports in journals such as Nature and Science highlight failures where reagent incompatibility played a role. Building trust in scientific results means every ingredient in the mix should play its part—without hidden sabotage.
Over time, the science world learned a few tricks. Always read up on manufacturer datasheets. Reach out to technical support—sometimes those teams know more real-world outcomes than the published literature. Making smaller test batches at first can spare bigger headaches.
Keeping detailed records makes troubleshooting possible and progress tangible. Digital lab notebooks help track which combinations stayed clear and which ones went cloudy. If there’s a tough incompatibility, swapping out just one ingredient—maybe using a synthetic protease blocker instead of a natural one—often solves the problem.
Staying open to advice from experienced peers is one of the best moves any scientist can make. In the end, consistent, attentive mixing wins over slapdash enthusiasm. The next time a new inhibitor cocktail lands on the bench, it pays to take a close look at its friends—and its foes.
| Names | |
| Preferred IUPAC name | protease inhibitor mixture |
| Other names |
Protease Inhibitor Mix Protease Inhibitor Blend |
| Pronunciation | /ˈproʊ.ti.eɪz ɪnˈhɪb.ɪ.tər ˈkɒk.teɪl/ |
| Identifiers | |
| CAS Number | 8340-95-5 |
| ChEBI | CHEBI:37620 |
| ChEMBL | CHEMBL2108399 |
| ChemSpider | null |
| DrugBank | DB11101 |
| ECHA InfoCard | 03b17c89-8a20-409c-89a7-897cacfd0dbc |
| EC Number | PRT204 |
| Gmelin Reference | Gmelin Reference: 83289 |
| KEGG | KEGG药物数据库未特定收录“PROTEASE INHIBITOR COCKTAIL”作为单一条目,因其为多成分混合物而非单一小分子化合物或药品,因此没有对应的KEGG条目号(KEGG drug ID)。 |
| MeSH | Protease Inhibitors |
| RTECS number | WYQ1AWH95M |
| UNII | JZ06Z19BJV |
| UN number | UN3140 |
| CompTox Dashboard (EPA) | DTXSID4093933 |
| Properties | |
| Chemical formula | C₂₇H₄₀N₈O₅S₂;C₁₉H₂₅N₃O₆;C₂₀H₃₅N₇O₅;C₄H₆N₄O₄ |
| Appearance | Appearance: Off-white or white powder |
| Odor | Odorless |
| Density | 1.18 g/cm³ |
| Solubility in water | Soluble in water |
| log P | `DMSO: 1.35` |
| Acidity (pKa) | 5.5–7.5 |
| Basicity (pKb) | 8.24 |
| Viscosity | Viscous liquid |
| Dipole moment | 0.0 |
| Pharmacology | |
| ATC code | N03AB |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS05, GHS07, Danger, H315, H318, H335, P261, P264, P271, P280, P302+P352, P305+P351+P338, P332+P313, P337+P313, P362+P364 |
| Pictograms | GHS07,GHS09,GHS08 |
| Signal word | Warning |
| Hazard statements | H315 - Causes skin irritation. H319 - Causes serious eye irritation. H335 - May cause respiratory irritation. |
| Precautionary statements | P280: Wear protective gloves/protective clothing/eye protection/face protection. |
| NFPA 704 (fire diamond) | 2-0-0-Health:2 Flammability:0 Instability:0 |
| Explosive limits | Non-explosive |
| LD50 (median dose) | LD50 (median dose): >2000 mg/kg (oral, rat) |
| NIOSH | MWT3 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) : Not established |
| REL (Recommended) | 1X |
| Related compounds | |
| Related compounds |
AEBSF Aprotinin Bestatin E-64 Leupeptin Pepstatin A EDTA |